US 11530393
Compositions comprising iduronate-2-sulfatase
granted A61KA61K38/465A61P
Quick answer
US patent 11530393 (Compositions comprising iduronate-2-sulfatase) held by Takeda Pharmaceutical Company Limited expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/465, A61P, A61P25/00, A61P3/00